Atlas Trials

Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma

Clinical trial NCT05755828 · UNKNOWN

Trial details

NCT number
NCT05755828
Sponsor
The Affiliated Hospital of Xuzhou Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
B-cell Lymphoma
Start date
2022-12-01
Primary completion
2024-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.